Age-Related
-
A landmark study is due to start in the coming months, and if successful it could ultimately revive our immune system in older age and even treat chronic illnesses like autoimmune disease. The Phase 1 trial is aiming to rejuvenate senescent T cells.
-
A company known for its AI image generation has made a surprise pivot – to healthcare. Midjourney says it will deliver a "new form of medical imaging" to map the body, in a day-spa setting, with the first center due to open to the public in 2027.